
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1040 | 957 | 1040 | 910 | 1148 | 1675 |
Fund Return | 3.97% | -4.29% | 3.97% | -3.09% | 2.8% | 5.29% |
Place in category | 552 | 182 | 552 | 409 | 357 | 191 |
% in Category | 83 | 27 | 83 | 74 | 75 | 63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Raiffeisen Pension Invest Futura Ba | 4B | 6.47 | -2.59 | 1.75 | ||
Raiffeisen Pension Invest Futura BI | 4B | 0.67 | -0.03 | 1.59 | ||
Raiffeisen Futura Swiss Stock A | 2.03B | 5.94 | -3.58 | 5.89 | ||
Raiffeisen Pension Invest Futura YA | 1.29B | 4.01 | -2.95 | 0.39 | ||
Raiffeisen Pension Invest Futura YI | 1.29B | 0.01 | -0.73 | 0.21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.34B | 9.97 | 4.26 | 6.64 | ||
Pictet CH Institutional Swiss EquiZ | 1.91B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 1.91B | 6.32 | 1.38 | 6.61 | ||
Pictet CH Institutional Swiss EquZD | 1.91B | 6.45 | 1.86 | 7.11 | ||
Pictet CH Institutional Swiss EquiP | 1.91B | 6.27 | 1.17 | 6.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 12.02 | 243.80 | +0.33% | |
Nestle | CH0038863350 | 11.34 | 84.98 | +0.81% | |
Novartis | CH0012005267 | 10.27 | 86.09 | +1.63% | |
UBS Group | CH0244767585 | 5.88 | 22.80 | -0.44% | |
ABB | CH0012221716 | 5.74 | 40.27 | -2.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review